{
    "clinical_study": {
        "@rank": "40201", 
        "arm_group": [
            {
                "arm_group_label": "Transconjunctival needling revision", 
                "arm_group_type": "Experimental", 
                "description": "Eyes with primary glaucoma surgery failure with encapsulated bleb submitted to surgical revision"
            }, 
            {
                "arm_group_label": "Medical treatment", 
                "arm_group_type": "Active Comparator", 
                "description": "Eyes with primary glaucoma surgery failure with encapsulated blebs were treated with medical treatment (hypotensive eye drops)"
            }
        ], 
        "brief_summary": {
            "textblock": "When the glaucoma filtering surgery failures (intraocular pressure rises again), the options\n      is start to use the hypotensive eye drops again (medical treatment). However, in some cases\n      (encapsulated blebs), there is a simple surgical revision that can revival the primary\n      failure surgery. It calls transconjunctival needling revision. In this study, the\n      investigators compare the efficacy of this revision versus medical treatment in 12-month\n      follow up in eyes with encapsulated blebs."
        }, 
        "brief_title": "Transconjunctival Needling Revision Versus Medical Treatment", 
        "completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "condition": "Primary Open Angle Glaucoma", 
        "condition_browse": {
            "mesh_term": [
                "Glaucoma", 
                "Glaucoma, Open-Angle"
            ]
        }, 
        "detailed_description": {
            "textblock": "To compare the efficacy of transconjunctival needling revision (TNR) with 5-fluorouracil\n      versus medical treatment (MT) in glaucomatous eyes with uncontrolled intraocular pressure\n      (IOP) due to encapsulated bleb after trabeculectomy Prospective, randomized, interventional\n      study. A total of forty eyes of 39 patients with elevated IOP and encapsulated bleb\n      diagnosed at maximum 5 months after primary trabeculectomy with mitomycin C were included.\n      The eyes were randomized to either TNR with 5-fluorouracil or MT (hypotensive eyedrops). A\n      maximum of two TNR per patient was allowed in the needling arm. All eyes were followed up\n      for 12 months. Success of treatment was defined as IOP \u2264 18mmHg and 20% reduction from\n      baseline at last follow up."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Eyes with encapsulated blebs developed in 5 months or less following primary glaucoma\n             filtering surgery (trabeculectomy) and intraocular pressure >= 20mmHg\n\n        Exclusion Criteria:\n\n          -  Previous other ocular surgery"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 24, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01887223", 
            "org_study_id": "TNRVMT-RS"
        }, 
        "intervention": [
            {
                "arm_group_label": "Transconjunctival needling revision", 
                "description": "Surgical revision. A 25 Gauge needle was inserted under the subconjunctival space and perforate the encapsulated bled. The encapsulated bleb was ruptured with sweeping movement up and down, back and forth.", 
                "intervention_name": "Transconjunctival needling revision", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "Medical treatment", 
                "description": "Hypotensive eye drops are initialized one by one regarding intraocular pressure control. Nonspecific beta blocker and/or prostaglandin, followed by carbonic anhydrase inhibitors and/or selective alpha agonist.", 
                "intervention_name": "Medical treatment", 
                "intervention_type": "Drug", 
                "other_name": [
                    "Timoptol 0,5%", 
                    "Xalatan", 
                    "Trusopt", 
                    "Alphagan"
                ]
            }
        ], 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "keyword": [
            "Encapsulated blebs", 
            "trabeculectomy failure", 
            "glaucoma"
        ], 
        "lastchanged_date": "June 26, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Sao Paulo", 
                    "country": "Brazil"
                }, 
                "name": "University of Sao Paulo General Hospital"
            }
        }, 
        "location_countries": {
            "country": "Brazil"
        }, 
        "number_of_arms": "2", 
        "official_title": "Early Transconjunctival Needling Revision With 5-fluorouracil Versus Medical Treatment in Encapsulated Blebs: a 12-month Prospective Study", 
        "overall_official": [
            {
                "affiliation": "University of Sao Paulo General Hospital", 
                "last_name": "Remo Susanna Jr., MD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "University of Sao Paulo General Hospital", 
                "last_name": "Ricardo Suzuki, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Brazil: CAPPesq from University of Sao Paulo General Hospital", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 2", 
        "primary_completion_date": {
            "#text": "June 2011", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "measure": "Intraocular pressure", 
            "safety_issue": "Yes", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01887223"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Sao Paulo General Hospital", 
            "investigator_full_name": "Ricardo Suzuki", 
            "investigator_title": "Assistant professor of Ophthalmology at HCFMUSP", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "results_reference": {
            "PMID": "9261306", 
            "citation": "Costa VP, Correa MM, Kara-Jose N. Needling versus medical treatment in encapsulated blebs. A randomized, prospective study. Ophthalmology. 1997 Aug;104(8):1215-20."
        }, 
        "source": "University of Sao Paulo General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Sao Paulo General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2010", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "June 2013"
    }
}